(Q50765589)

English

Pre-transplant reduction of isohaemagglutinin titres by donor group plasma infusion does not reduce the incidence of pure red cell aplasia in major ABO-mismatched transplants.

scientific article published in August 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/15908965

Pre-transplant reduction of isohaemagglutinin titres by donor group plasma infusion does not reduce the incidence of pure red cell aplasia in major ABO-mismatched transplants. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/15908965

author name string

Damodar S

1

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/15908965

George B

2

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/15908965

Mammen J

3

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/15908965

Mathews V

4

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/15908965

Srivastava A

5

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/15908965

Chandy M

6

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/15908965

language of work or name

0 references

publication date

1 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/15908965

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/15908965

36

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/15908965

3

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/15908965

233-235

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/15908965

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705031

0 references

Plasma exchange and plasma modification for the removal of anti-red cell antibodies prior to ABO-incompatible marrow transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705031

21 January 2018

Whole blood immunoadsorption of anti-A or anti-B antibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705031

21 January 2018

ABH incompatible bone marrow transplantation: removal of erythrocytes by starch sedimentation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705031

21 January 2018

Immunohematologic problems associated with bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705031

7 January 2021

based on heuristic

inferred from DOI database lookup

The histo-blood group ABO system and tissue transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705031

7 January 2021

based on heuristic

inferred from DOI database lookup

Graft-versus-host disease and survival after ABO-incompatible allogeneic bone marrow transplantation: a single-centre experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705031

7 January 2021

based on heuristic

inferred from DOI database lookup

ABO-incompatible marrow transplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705031

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohematologic consequences of major ABO-mismatched bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705031

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705031

7 January 2021

based on heuristic

inferred from DOI database lookup

Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705031

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1705031

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/15908965

release_j6z2q2in5jfezf3kimopsvh3yy

1 reference

https://api.fatcat.wiki/v0/release/j6z2q2in5jfezf3kimopsvh3yy

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/15908965

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50765589&oldid=1842085133"